6th International Conference: Genomic Medicine Implementation in Low Resource Settings

第六届国际会议：资源匮乏环境下的基因组医学实施

• 批准号: 10318318
• 负责人: GABRIELA REPETTO
• 金额: $ 3.64万
• 依托单位: GLOBAL GENOMIC MEDICINE COLLABORATIVE
• 依托单位国家: 美国
• 财政年份: 2021
• 资助国家: 美国
• 起止时间: 2021-09-21 至 2022-02-28
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10318318
• 关键词: Academia; Achievement; Advocate; Affect; COVID-19 pandemic; Caring; Chile; Clinical Trials; Collaborations; Communities; Country; Development; Diagnosis; Discipline; Disease; Education; Elements; Epidemiologist; Event; Family; Fostering; Future; Genomic medicine; Genomics; Geography; Goals; Government; Health; Health Personnel; Health system; Healthcare; Human; Hybrids; Income; Individual; Industry; International; Investments; Latin America; Lead; Leadership; Location; Malignant Neoplasms; Mentors; Mentorship; Outcome; Participant; Patients; Persons; Pharmacogenomics; Physicians; Play; Policies; Policy Maker; Population Heterogeneity; Prevention; Privatization; Probability; Rare Diseases; Recording of previous events; Research; Research Personnel; Resources; Risk; Role; Scientist; System; Time; Training; Travel; Uncertainty; Underrepresented Populations; United States; Work; base; career; career development; clinical application; cost; demographics; evidence based guidelines; health care availability; health care delivery; implementation science; improved; meetings; member; outreach; patient population; population health; posters; programs; success; symposium; therapeutic development; virtual; working group

Abstract The Global Genomics Medicine Collaborative (G2MC) requests support for its 6th International Conference: Genomic Medicine Implementation in Low Resource Settings, organized by Drs. Geoffrey S. Ginsburg, Gabriela Repetto and Bruce Korf. The event will be held on September 29 - October 1, 2021 in Santiago, Chile. G2MC is a not-for-profit organization based in the United States with the goal of bringing together the global community to enable the implementation of genomic medicine to improve individual and population health. Many nations are investing in large-scale national genomic medicine programs. To maximize the value of this investment, we propose this gathering as a means to ‘de-silo’ these efforts and bring them together to inform implementation into healthcare delivery systems across diverse populations, demographics, and economies. To optimize the probability of success for implementing genomics into health care is it necessary to bring the leaders at the forefront of genomic medicine together in a forum conducive to impactful conversations and dialogues. While genomic medicine offers major opportunities for prevention, diagnosis, and treatment of disease, there is a significant risk that it will exacerbate disparities in access to healthcare. This is true in high-income countries such as the United States but is even more a concern in low resource settings (LRS). G2MC has selected the event location to enable engagement with regional attendees from Latin America, a traditionally underrepresented group in genomic medicine. The conference agenda will facilitate a deeper understanding of best practices from subject matter experts that can be applied to genomic medicine and advancement of G2MC’s implementation Flagship Projects. The conference will also provide a unique opportunity to mentor Young Investigators (YIs) from lower- and middle-resourced countries in Latin America and beyond by established G2MC investigators and high-profile speakers from around the world with expertise in genomic medicine. Given the current COVID-19 pandemic, this meeting is planned as a hybrid in-person and virtual event. G2MC will encourage YIs to attend in person, if possible, so as to increase their visibility, and highlight their achievements. An explicit goal of this meeting is to advance the careers of YIs through their interaction with G2MC members/investigators through mentorship, networking, dissemination of their research. YIs will also engage with G2MC Flagship Projects and working groups, leading to further opportunities for collaboration. The 6th International G2MC Conference is unique in emphasizing implementation through outreach with YIs as well as speaker and attendee representation from LRS. The agenda objectives emphasize solutions to implementation roadblocks by engaging with a truly global group of presenters and attendees to enable the successful implementation of genomic medicine around the world.

摘要 全球基因组学医学合作组织（G2 MC）请求支持其第六届国际会议： 低资源环境下的基因组医学实施，由杰弗里·S。金斯伯格， 加布里埃拉·雷佩托和布鲁斯·考夫。该活动将于2021年9月29日至10月1日在圣地亚哥举行， 智利. G2 MC是一个总部设在美国的非营利组织，其目标是将 全球社区，使基因组医学的实施，以改善个人和人口 健康许多国家正在投资大规模的国家基因组医学计划。价值最大化 在这项投资中，我们建议将这次聚会作为一种手段，以“去孤岛”这些努力，并将它们聚集在一起， 在不同人群、人口统计数据和 经济体为了优化将基因组学应用于医疗保健的成功概率， 将基因组医学前沿的领导者聚集在一个有利于产生影响力的论坛上， 对话和对话。虽然基因组医学为预防、诊断和治疗提供了重要机会， 在疾病治疗方面，存在着一个很大的风险，即它将加剧在获得医疗保健方面的差距。这是 在美国等高收入国家确实如此，但在低资源环境中更令人担忧 （LRS）。G2 MC选择了活动地点，以便与拉丁美洲的区域与会者进行互动 美国，基因组医学领域传统上代表性不足的群体。会议议程将促进 更深入地了解可应用于基因组医学的主题专家的最佳实践 并推进G2 MC的旗舰项目的实施。会议还将提供一个独特的 有机会指导来自拉丁美洲中低资源国家的青年研究者（YIs） 由来自世界各地的知名G2 MC调查人员和知名演讲者提供专业知识， 在基因组医学中。鉴于当前的COVID-19大流行，本次会议计划为混合面对面会议， 虚拟事件。G2 MC将鼓励YI在可能的情况下亲自参加，以提高他们的知名度， 突出他们的成就。这次会议的一个明确目标是通过他们的职业生涯来推进YIs的职业生涯。 与G2 MC成员/研究人员通过指导，网络，传播他们的研究进行互动。 YIs还将参与G2 MC旗舰项目和工作组，为以下方面提供更多机会： 协作第六届国际G2 MC会议的独特之处在于强调通过 与YIs以及LRS的演讲者和与会者代表进行外联。议程目标 通过与真正的全球演讲者团队合作，强调解决实施障碍的方法， 与会者，使基因组医学在世界各地的成功实施。